[1] ANDERS CK, CAREY LA.Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer[J].Clin Breast Cancer, 2009, 9(Suppl 2):S73.
[2] LEHMANN BD, BAUER JA, CHEN X, et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest, 2011, 121(7):2750. doi: 10.1172/JCI45014
[3] BURSTEIN MD, TSIMELZON A, POAGE GM, et al.Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer[J].Clin Cancer Res, 2015, 21(7):1688. doi: 10.1158/1078-0432.CCR-14-0432
[4] DU HY, LIN BR, HUANG DP.Ultrasonographic findings of triple-negative breast cancer[J].Int J Clin Exp Med, 2015, 8(6):10040.
[5] YANG Q, LIU HY, LIU D, et al.Ultrasonographic features of triple-negative breast cancer:a comparison with other breast cancer subtypes[J].Asian Pac J Cancer Prev, 2015, 16(8):3229. doi: 10.7314/APJCP.2015.16.8.3229
[6] JUNG HK, HAN K, LEE YJ, et al.Mammographic and sonographic features of triple-negative invasive carcinoma of no special type[J].Ultrasound Med Biol, 2015, 41(2):375. doi: 10.1016/j.ultrasmedbio.2014.09.006
[7] LI B, ZHAO X, DAI SC, et al.Associations between mammography and ultrasound imaging features and molecular characteristics of triple-negative breast cancer[J].Asian Pac J Cancer Prev, 2014, 15(8):3555. doi: 10.7314/APJCP.2014.15.8.3555
[8] 陈圆圆, 李智贤, 魏晏平, 等.超声联合钼靶X线对三阴性乳腺癌的诊断价值[J].重庆医学, 2013, 42(30):3662. doi: 10.3969/j.issn.1671-8348.2013.30.027
[9] 张桦, 崔志英, 严梦寒, 等.超声及钼靶在三阴性乳腺癌诊断中的价值[J].医药论坛杂志, 2016, 37(4):43.
[10] 朱明华, 阳泽龙, 胡朔枫, 等.三阴性乳腺癌临床病理特征及其与预后的关系[J].空军医学杂志, 2015, 31(2):89.
[11] 廖仕翀, 喻莉, 唐和孝, 等.三阴性乳腺癌危险因素及临床特征分析[J].中华实用诊断与治疗杂志, 2016, 30(11):1075.
[12] HAMM C, EL-MASRI M, POLIQUIN G, et al.A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis[J].Curr Oncol, 2011, 18(4):191.
[13] 杨猛, 戴殿禄, 崔国忠, 等.三阴性与非三阴性乳腺癌的临床病理分类与病理特征研究[J].现代中西医结合杂志, 2015, 24(24):2713. doi: 10.3969/j.issn.1008-8849.2015.24.037
[14] HASHMI AA, EDHI MM, NAQVI H, et al.Clinicopathologic features of triple negative breast cancers:an experience from Pakistan[J].Diagn Pathol, 2014, 9(1):43.
[15] QIU J, XUE X, HU C, et al.Comparison of clinicopathological features and prognosis in triple-negative and non-triple negative breast cancer[J].J Cancer, 2016, 7(2):167. doi: 10.7150/jca.10944
[16] GOGIA A, RAINA V, DEO SV, et al.Triple-negative breast cancer:An institutional analysis[J].Indian J Cancer, 2014, 51(2):163. doi: 10.4103/0019-509X.138275
[17] AKHTAR M, DASGUPTA S, RANGWALA M.Triple negative breast cancer:an Indian perspective[J].Breast Cancer(Dove Med Press), 2015, 7:239.
[18] NABI MG, AHANGAR A, WAHID MA, et al.Clinicopathological comparison of triple negative breast cancers with non-triple negative breast cancers in a hospital in North India[J].Niger J Clin Pract, 2015, 18(3):381. doi: 10.4103/1119-3077.153248
[19] ONITILO AA, ENGEL JM, GREENLEE RT, et al.Breast cancer subtypes based on ER/PR and Her2 expression:comparison of clinicopathologic features and survival[J].Clin Med Res, 2009, 7(1/2):4.
[20] GHOSN M, HAJJ C, KATTAN J, et al.Triple-negative breast cancer in Lebanon:a case series[J].Oncologist, 2011, 16(11):1552. doi: 10.1634/theoncologist.2011-0088
[21] DENT R, TRUDEAU M, PRITCHARD KI, et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res, 2007, 13(15 Pt 1):4429.
[22] 王雅杰, 王宁, 王斌, 等.三阴性乳腺癌与人表皮生长因子受体2过表达乳腺癌病人的临床病理特征和预后比较[J].中华肿瘤杂志, 2009, 31(5):346. doi: 10.3760/cma.j.issn.0253-3766.2009.05.006
[23] LEE JH, KIM SH, SUH YJ, et al.Predictors of axillary lymph node metastases(ALNM) in a Korean population with T1-2 breast carcinoma:triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size[J].Cancer Res Treat, 2010, 42(1):30. doi: 10.4143/crt.2010.42.1.30
[24] STEWARD L, CONANT L, GAO F, et al.Predictive factors and patterns of recurrence in patients with triple negative breast cancer[J].Ann Surg Oncol, 2014, 21(7):2165. doi: 10.1245/s10434-014-3546-4
[25] SCHMIDT G, MEYBERG-SOLOMAYER G, GERLINGER C, et al.Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression[J].Arch Gynecol Obstet, 2014, 290(6):1221. doi: 10.1007/s00404-014-3331-4
[26] DENT R, HANNA WM, TRUDEAU M, et al.Time to disease recurrence in basal-type breast cancers:effects of tumor size and lymph node status[J].Cancer, 2009, 115(21):4917. doi: 10.1002/cncr.v115:21